Holdings
JPMorgan Healthcare Leaders ETF
As of Jul 31, 2026, JPMorgan Healthcare Leaders ETF reported 53 positions worth US$8.94M. Largest: Abbvie Inc., Eli Lilly And Company and Unitedhealth Group Incorporated. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Abbvie Inc. | 2,838 | US$712K | −626 | Jul 31, 2026 |
| Eli Lilly And Company | 613 | US$704K | −198 | Jul 31, 2026 |
| Unitedhealth Group Incorporated | 1,281 | US$531K | −470 | Jul 31, 2026 |
| Merck & Company, Inc. | 3,359 | US$437K | −930 | Jul 31, 2026 |
| Johnson & Johnson | 1,706 | US$437K | −1,295 | Jul 31, 2026 |
| Astrazeneca Plc | 2,007 | US$341K | −670 | Jul 31, 2026 |
| Thermo Fisher Scientific Inc | 590 | US$339K | −150 | Jul 31, 2026 |
| Bristol-myers Squibb Company | 4,962 | US$324K | −1,465 | Jul 31, 2026 |
| Abbott Laboratories | 2,669 | US$282K | new | Jul 31, 2026 |
| Cvs Health Corporation | 2,458 | US$257K | −1,160 | Jul 31, 2026 |